This site is intended for U.S. healthcare professionals only.

Ordering Information for KENGREAL® (cangrelor)

KENGREAL® (cangrelor)
50 mg per vial

KENGREAL® 50 mg per vial

Carton: NDC 65293-003-10
Carton: 5.9 oz
Carton: 5.9 x 2.5 x 2.5 in (LxWxH)

Ordering information

KENGREAL® is a wholesaler-stocked product. Please use standard ordering procedure through your wholesaler. If product is not available at your wholesaler, your wholesaler can easily coordinate a drop shipment via Next-Day Saver from a Chiesi USA distribution provider.

Wholesaler item numbers for 50 mg/10 mL liquid vial

Wholesaler Wholesaler number
ABC 10153097
Cardinal 5106604
HD Smith 5486618
McKesson 3465796
Morris & Dickson 279026

For questions not answered on this website, contact Chiesi USA, Inc. Medical Information at 1-888-661-9260.

Product overview

How supplied

KENGREAL® is supplied as a sterile lyophilized powder in single-use 10 mL vials.

  • NDC 65293-003-01: 10 mL vial containing 50 mg KENGREAL®
  • NDC 65293-003-10: 10 count of 10 mL vials containing 50 mg KENGREAL®


Vials of KENGREAL® should be stored at USP Controlled Room Temperature [20°C to 25°C (68°F to 77°F) with excursions between 15°C and 30°C (59°F and 86°F) permitted].

Important Safety Information

KENGREAL® (cangrelor) for Injection is contraindicated in patients with significant active bleeding.

KENGREAL® is contraindicated in patients with known hypersensitivity (e.g., anaphylaxis) to cangrelor or any component of the product.

Drugs that inhibit platelet P2Y12 function, including KENGREAL®, increase the risk of bleeding. In CHAMPION PHOENIX, bleeding events of all severities were more common with KENGREAL® than with clopidogrel. Bleeding complications with KENGREAL® were consistent across a variety of clinically important subgroups. Once KENGREAL® is discontinued, there is no antiplatelet effect after an hour.

The most common adverse reaction is bleeding.

Please see full prescribing information.

This site is intended for U.S. healthcare professionals. If you are a U.S. healthcare professional, click OK to continue.